Article

The effect of oleoylethanolamide supplementation on pyroptotic cell death in obese patients with non-alcoholic fatty liver disease: A double-blinded randomized controlled clinical trial

2022-06-16

Abstract excerpt

<h4>Background: </h4> Non-alcoholic fatty liver disease (NAFLD) is now the main contributor to the worldwide chronic liver diseases. Pyroptosis has recently gained interest as a pathway for hepatocyte death under liver injuries. Blocking nucleotide-binding oligomerization domain-like receptor family pyrin domain containing 3 (NLRP3)-Inflammasome, a prominent player in the pyroptosis pathway, has been indicated to...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work: 56451d6e-4f42-54e4-9294-f201c9656676
DOI: 10.21203/rs.3.rs-1736983/v1

Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest

The effect of oleoylethanolamide supplementation on pyroptotic cell death in obese patients with non-alcoholic fatty liver disease: A double-blinded randomized controlled clinical trialDOI 10.21203/rs.3.rs-1736983/v1Read

Non-alcoholic steatohepatitis: pathogenesis and novel therapeutic approaches.Semantic proximity Read

Nonalcoholic fatty liver disease.Semantic proximity Read

Common Pathogenetic Pathways of Non-Alcoholic Fatty Liver Disease and Type 2 Diabetes MellitusSemantic proximity Read

Adiponectin inhibits palmitic acid-induced NLRP3 inflammasome activation in hepatocytes through AMPK-JNK/ErK1/2-NFκB/ROS signaling pathwaysSemantic proximity Read

Non-alcoholic fatty liver disease: what the clinician needs to know.Semantic proximity Read

Non-alcoholic fatty liver disease pathogenesis: the present and the future.Semantic proximity Read

Mitophagy as a pivotal axis in non‑alcoholic fatty liver disease: From pathogenic mechanisms to therapeutic strategies (Review)Semantic proximity Read

Identification of pyroptosis-related gene signature in nonalcoholic steatohepatitisSemantic proximity Read

A review of non-alcoholic fatty liver disease in non-obese and lean individuals.Semantic proximity Read

[Non-alcoholic fatty liver disease and hepatocellular carcinoma - 2016].Semantic proximity Read

Gastrointestinal complications of obesity: non-alcoholic fatty liver disease (NAFLD) and its sequelae.Semantic proximity Read

[Secondary causes of fatty liver disease - an update on pathogenesis, diagnosis and treatment strategies].Semantic proximity Read